In vivo acquired daptomycin resistance during treatment of methicillin-resistant Staphylococcus aureus endocarditis

International Journal of Infectious Diseases

Volumn 17, Issue 11, 2013, Pages e1076-e1077

  Dortet, Laurent ^a,b   Anguel, Nadia ^a   Fortineau, Nicolas ^a   Richard, Christian ^a   Nordmann, Patrice ^a,b  

^a BICÊTRE HOSPITAL   (France)

^b Associated French National Reference Center for Antibiotic Resistance: Carbapenemase producing Enterobacteriaceae   (France)

Author keywords

Daptomycin resistance; Endocarditis; Methicillin resistant Staphylococcus aureus; Septicemia

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN PLUS CLAVULANIC ACID; CHLORAMPHENICOL; COTRIMOXAZOLE; DAPTOMYCIN; FUSIDIC ACID; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN; VORICONAZOLE;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; ARTIFICIAL VENTILATION; ASPERGILLUS; BACTERIAL ENDOCARDITIS; CASE REPORT; CATHETER INFECTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTINUOUS INFUSION; FEMALE; HUMAN; HYPOVOLEMIA; INTENSIVE CARE UNIT; LUNG LAVAGE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; PNEUMONIA; TREATMENT DURATION;

DAPTOMYCIN RESISTANCE; ENDOCARDITIS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; SEPTICEMIA;

ANTI-BACTERIAL AGENTS; DAPTOMYCIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENDOCARDITIS, BACTERIAL; FEMALE; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; STAPHYLOCOCCAL INFECTIONS;

EID: 84885384649     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2013.02.019     Document Type: Article

References (5)

1. Moreillon P., Que Y.A. Infective endocarditis. Lancet 2004, 363:139-149.
2. Fowler V.G., Miro J.M., Hoen B., Cabell C.H., Abrutyn E., Rubinstein E., et al. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 2005, 293:3012-3021.
3. Baltz R.H. Daptomycin: mechanisms of action and resistance, and biosynthetic engineering. Curr Opin Chem Biol 2009, 13:144-151.
4. Benvenuto M., Benziger D.P., Yankelev S., Vigliani G. Pharmacokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteers. Antimicrob Agents Chemother 2006, 50:3245-3249.
5. Fowler V.G., Boucher H.W., Corey G.R., Abrutyn E., Karchmer A.W., Rupp M.E., et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 2006, 355:653-665.